Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Express Scripts Rewards Low List-Priced Brands In 2019 Formulary, Retains Focus On Rebates

Aug 07 2018

• By Cathy Kelly

Express Scripts HQ

Related Content

Express Scripts Boosts Formulary Exclusions With Focus On Multi-Source Brands

Aug 01 2017

Mylan Plans To Compete In US HIV Market With Two Fixed-Dose Combos

Mar 05 2018

Merck's New Pricing Pledge Shows Style Over Substance

Jul 20 2018

Related Companies

Express Scripts Holding Company

Viatris Inc.

Merck & Co., Inc.

Gilead Sciences, Inc.

AbbVie Inc.

Novartis AG

Biogen, Inc.

Bayer AG

Merck KGaA

Sanofi

Eli Lilly and Company

Boehringer Ingelheim GmbH

Kaléo Pharmaceutical Inc.

Amneal Pharmaceuticals, Inc.

Lineage Biomedical Inc.

Amgen, Inc.

Additional Topics

United States Pricing Strategies Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window